Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA

Lancet

Volumn 349, Issue 9062, 1997, Pages 1368-

  Goedert, James J ^a   Kedes, Dean H ^b   Ganem, Don ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; CANCER RISK; COHORT ANALYSIS; FEMALE; HAITI; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; KAPOSI SARCOMA; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; SEROPREVALENCE; UNITED STATES;

EID: 0342981635     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63204-7     Document Type: Article

References (4)

1. Kedes D, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997; 277: 478-81.
2. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-28.
3. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet 1989; 334: 1351-55.
4. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.